BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 16002022)

  • 1. The impact of a reduction in drug supply on demand for and compliance with treatment for drug dependence.
    Degenhardt L; Conroy E; Day C; Gilmour S; Hall W
    Drug Alcohol Depend; 2005 Aug; 79(2):129-35. PubMed ID: 16002022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a sustained heroin shortage in three Australian States.
    Degenhardt L; Day C; Dietze P; Pointer S; Conroy E; Collins L; Hall W
    Addiction; 2005 Jul; 100(7):908-20. PubMed ID: 15954999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age differentials in the impacts of reduced heroin: effects of a "heroin shortage" in NSW, Australia.
    Degenhardt L; Day C; Conroy E; Gilmour S; Hall W
    Drug Alcohol Depend; 2005 Sep; 79(3):397-404. PubMed ID: 15927418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in patterns of drug use among injecting drug users following changes in the availability of heroin in New South Wales, Australia.
    Roxburgh A; Degenhardt L; Breen C
    Drug Alcohol Rev; 2004 Sep; 23(3):287-94. PubMed ID: 15370008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of changes to heroin supply on blood-borne virus notifications and injecting related harms in New South Wales, Australia.
    Day C; Degenhardt L; Gilmour S; Hall W
    BMC Public Health; 2005 Aug; 5():84. PubMed ID: 16102177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Documenting the heroin shortage in New South Wales.
    Day C; Degenhardt L; Hall W
    Drug Alcohol Rev; 2006 Jul; 25(4):297-305. PubMed ID: 16854654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the heroin 'drought' on patterns of drug use and drug-related harms.
    Longo MC; Henry-Edwards SM; Humeniuk RE; Christie P; Ali RL
    Drug Alcohol Rev; 2004 Jun; 23(2):143-50. PubMed ID: 15370019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a reduction in heroin availability on patterns of drug use, risk behaviour and incidence of hepatitis C virus infection in injecting drug users in New South Wales, Australia.
    Maher L; Li J; Jalaludin B; Wand H; Jayasuriya R; Dixon D; Kaldor JM
    Drug Alcohol Depend; 2007 Jul; 89(2-3):244-50. PubMed ID: 17289299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of law enforcement activity on a heroin market.
    Weatherburn D; Lind B
    Addiction; 1997 May; 92(5):557-69; discussion 611-3. PubMed ID: 9219378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cocaine and heroin markets in the era of globalisation and drug reduction policies.
    Costa Storti C; De Grauwe P
    Int J Drug Policy; 2009 Nov; 20(6):488-96. PubMed ID: 19447024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of illicit drug supply reduction on health and social outcomes: the heroin shortage in the Australian Capital Territory.
    Smithson M; McFadden M; Mwesigye SE; Casey T
    Addiction; 2004 Mar; 99(3):340-8. PubMed ID: 14982547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of methamphetamine and heroin price on polydrug use: A behavioural economics analysis in Sydney, Australia.
    Chalmers J; Bradford D; Jones C
    Int J Drug Policy; 2010 Sep; 21(5):381-9. PubMed ID: 20619627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of borderline personality disorder on 12-month outcomes for the treatment of heroin dependence.
    Darke S; Ross J; Williamson A; Teesson M
    Addiction; 2005 Aug; 100(8):1121-30. PubMed ID: 16042642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of illicit drug market changes on health agency operations in Sydney, Australia.
    Gibson A; Day C; Degenhardt L
    J Subst Abuse Treat; 2005 Jan; 28(1):35-40. PubMed ID: 15723730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between cocaine use and short-term outcomes for the treatment of heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Williamson A; Darke S; Ross J; Teesson M
    Drug Alcohol Rev; 2006 Mar; 25(2):141-8. PubMed ID: 16627303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and quantification of change in Australian illicit drug markets.
    Gilmour S; Koch I; Degenhardt L; Day C
    BMC Public Health; 2006 Aug; 6():200. PubMed ID: 16884546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the initiation of heroin use after a reduction in heroin supply.
    Day C; Degenhardt L; Hall W
    Drug Alcohol Rev; 2006 Jul; 25(4):307-13. PubMed ID: 16854655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of methamphetamine precursor chemical legislation, a suppression policy, on the demand for drug treatment.
    Cunningham JK; Liu LM
    Soc Sci Med; 2008 Apr; 66(7):1463-73. PubMed ID: 18222587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial of interim methadone maintenance.
    Schwartz RP; Highfield DA; Jaffe JH; Brady JV; Butler CB; Rouse CO; Callaman JM; O'Grady KE; Battjes RJ
    Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of post-traumatic stress disorder on treatment outcomes for heroin dependence.
    Mills KL; Teesson M; Ross J; Darke S
    Addiction; 2007 Mar; 102(3):447-54. PubMed ID: 17298653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.